Medical Equipment and Services Companies Worldwide

Open Bionics: Open Bionics is a prosthetics company developing affordable, assistive devices that enhance the human body. We've started by introducing the Hero Arm, a stylish multi-grip bionic arm. Current upper limb prostheses exist as hooks, grippers, or expensive bionic hands. We're on a mission to make beautiful bionic limbs more accessible. Aged 17, Joel Gibbard began tinkering with robotic hands. There was something about the movement of a disembodied humanoid hand that captured his imagination. Hundreds of prototypes and many crates of failures later, in 2014, Joel co-founded Open Bionics with Samantha Payne. With the help of an awesome team and the support of the limb different community, they’re pioneering a new bionic age inspired by science fiction. www.openbionics.com The Hero Arm: The Hero Arm is Open Bionics' first commercially available bionic limb. The Hero Arm is the most affordable multi-grip bionic arm ever, less than half the price of its nearest competitor. Each Hero Arm is custom-built, and for the first time ever is available for upper limb amputees as young as nine.

Optellum was founded so that every lung cancer patient is treated at the earliest possible stage, and cured. We are redefining early interception of lung disease, by enabling every clinician, in every hospital, to manage their patients in the optimal way. Our first product is the first Clinical Decision Support software for personalized early diagnosis & treatment of lung cancer, based on Artificial Intelligence & Machine Learning applied to the world’s largest clinical dataset. We are a team of world-leading medical imaging software, AI, and clinical experts who met at Oxford’s world-renowned computer vision laboratory. Between us, we have track records of bringing innovation to market through over 10 start-up companies, resulting already in 5 trade-sales and one IPO. We are backed by an Advisory Board comprising world-leading clinicians (global authors of medical guidelines) and experts in deep learning. We are building up our development team – join our fight against cancer, working together with former software engineers from top technology companies (Amazon, Facebook, Redhat) and veterans of medical imaging startups. Learn more at http://www.optellum.com/.

Optimo Medical AG is a 100% privatly held med-tech company in eye care. We are dedicated to design and develop, produce and distribute software applications for planning, simulation, visualization, and training of therapy. Each day, more than 50'000 eyes are operated on around the globe and not two of them have the exact same characteristics. Each eye has an individual and unique shape and biomechanical behavior. At the same time, only fractions of a millimeter can determine if the surgery is a success, or irreparable harm is caused. Due to the very complex nature of the human cornea, restored vision for patient on one side, and medical and financial damage on the other, as an outcome, lie very close together. Hence, one of the major challenges for the eye surgeon: Guessing how an individual eye might react to the necessary cuts into the cornea. Optimeyes 1.0 replaces guessing by knowing. Our software simulates effects of physical interference planned for the individual eye, with a precision that outperforms conventional, non-personalized methods by far. This has now been solved in the Optimeyes™ software. Optimizing the incision parameters to the individual cornea by accounting for age, preoperative astigmatism, central-, and paracentral curvature, full pachymetry, and corneal biomechanical characteristics is now possible. The OptimeyesTM arcuate keratotomy planning and optimization module features two different operation modes: Prediction and Optimization. Prediction calculates the post-surgery cornea, based on given AK parameters. Optimization calculates the optimal surgery parameters for the individual patient. The Optimeyes team of Optimo Medical AG has many years of experience in corneal biomechanics, numerical simulation (FEM), and corneal topography. We are capable of providing senior level consulting services for surgeons, R&D engineers, and product managers. For more information: www.optimo-medical.com / www.optimeyes.ch

We are a specialty pharmaceutical company focused on the development and commercialization of products for patients treated by ear, nose and throat (ENT) and allergy specialists. Our first commercial product, XHANCE® (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing our proprietary Exhalation Delivery System™ (EDS®) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps and, if approved, chronic rhinosinusitis without nasal polyps (also known as chronic sinusitis). In September 2017, the U.S. Food and Drug Administration (FDA) approved XHANCE for the treatment of nasal polyps in patients 18 years of age or older. XHANCE was made widely available through commercial channels in April 2018. In March and June 2022, we announced positive top line results from our two Phase 3b clinical trials (ReOpen1 and ReOpen2) of XHANCE for a follow-on indication for the treatment of chronic sinusitis. In February 2023, we submitted a prior approval efficacy supplement (sNDA) to support the approval of a new indication for XHANCE for the treatment of chronic rhinosinusitis. If the sNDA is approved, XHANCE has the potential to be the first drug therapy approved by the FDA for the treatment of chronic sinusitis. As of February 20, 2023, we had a total of 141 full-time employees all of whom are in the United States, and no part-time employees. Culture is a critical element in the management of our organization. Our colleagues are focused on driving our business with the Optinose values as the foundation for all our efforts. Our goal is that each colleague feels a deep connection to what they do, loves coming to work and is aligned to our One Mission – to improve lives. Our values of Authenticity, Fearless Conversations, Friendship, Openness, Perseverance and Possibility Thinking guide our actions and decisions.

OSE Immunotherapeutics is an integrated biotech company focused on developing first-in-class assets targeting cancer and inflammatory diseases. A current well-balanced first-in-class clinical pipeline including: • Tedopi® (T-cell specific immunotherapy): Company’s most advanced product; positive results for Ph 3 in NSCLC in secondary resistance after CKI failure. Other sponsored combo Ph 2 trials in solid tumors ongoing. • OSE-279 (anti-PD1) advanced preclinical stage • OSE-127 (humanized mAb antagonist of IL-7R); ongoing Ph 2 in Ulcerative Colitis; ongoing preclinical research in leukemia • VEL-101/FR104 (anti-CD28 mAb) developed in partnership with Veloxis in transplantation; ongoing Ph 1/2 in renal transplant (sponsor Nantes University Hospital); Ph 1 ongoing in the US (sponsor Veloxis). • BI 765063 (anti-SIRPα mAb on CD47/SIRPα pathway) developed in partnership with Boehringer Ingelheim in advanced solid tumors; positive Ph 1 dose escalation results in mono and in combo, in particular with anti-PD-1 antibody ezabenlimab; BI sponsored international Ph 1b clinical trial ongoing in combo with ezabenlimab alone or with other drugs in recurrent/metastatic HNSCC and HCC. OSE Immunotherapeutics expects to generate further significant value from its two proprietary drug discovery platforms, which are central to its ambitious goal to deliver next-generation first-in-class immunotherapeutics: • BiCKI® platform focused on immuno-oncology (IO) is a bispecific fusion protein platform built on the key backbone component of anti-PD1 combined with a new immunotherapy target to increase anti-tumor efficacy. Most advanced BiCKI® candidate is targeting anti-PD1xIL-7. • Myeloid platform focused on optimizing the therapeutic potential of myeloid cells in IO & immuno-inflammation (I&I). OSE-230 (ChemR23 agonist mAb), most advanced candidate generated by the platform, with the potential to resolve chronic inflammation.

Ostoform Ltd. is an Irish-based company that is certified to ISO 13485 for the design, manufacture and supply of ostomy products. The multi-award-winning company was born out of a need to improve skin health and quality of life for people who have an ostomy. Extensive research, bench testing and clinical studies have culminated in the development of a patented platform technology which manages ostomy skin health by addressing issues relating to appliance absorbency and leakage. Ostoform can now proudly introduce the Ostoform Seal with FLOWASSIST Protection.

We bring automated cell-monitoring solutions for cell & gene therapy, vaccine industry and life sciences applications. Our microscopes are easy-to-use, label-free and non-invasive tools for the three-dimensional, real-time imaging of living cells. Based on patented differential digital holography technology, our advanced systems generate reliable, high-quality holographic images providing highly-reproducible tracking of: - cell density - morphology - cell viability - viral infection kinetics - cell activation status Direct Benefits Our technology can benefit a range of applications, from R&D to manufacturing processes, and enable significant cost reduction and quality improvement. Our microscopes are particularly convenient and robust for automated cell culture monitoring, analysis and quality control.

Oxipit is a computer vision software startup specialized in medical imaging. With a team of award-winning data scientists and medical doctors, the company aims to introduce innovative Artificial Intelligence/Deep Learning breakthroughs to everyday clinical practice. Oxipit is the authors of CE certified multi-award winning ChestEye radiology imaging suite.

Established in 2002, Comen Medical Instruments Co.,Ltd., is a leading medical instruments and solutions provider in China dedicated in medical instrument development, manufacturing, sales and after-sales service in over 130 countries. With the mission of "Share with the world ", Comen contributes itself in delivering high-quality and high-performance medical instrument products and solutions to our clients in over 50,000 medical institutions worldwide. The company's main products and solutions are in the field of Monitoring Products Initiated by "All for the end users", Comprehensive NICU Solution, and Comprehensive OR/ICU Solution. Comen invests 10% of sales revenue to the R&D departments each year, and by now the R&D team has been expanded to over 500 engineers, and 65% of them are PhDs in Biomedical field. With the team of more than 1800 employees at 29 branch offices domestic and 7 subsidiaries overseas, Comen helps improve outcomes more efficiently for patients and healthcare professionals around the world.

Mission: The mission of Starfish vLabs is to develop technical expertise and share it openly for the benefit of our community. Strategy: To advance our mission at Starfish, we use our technical expertise to design, build and operate secure, resilient, and high-performance networks for our partners. About Us: Starfish vLabs is technology services business focused on the design and build of enterprise class networks using the latest technologies. Operating across all major network domains including campus, data centre and WAN, we work with the leading industry vendors such as Cisco, Juniper and VMware. We believe in the Starfish Principle; we know that we cannot fix all of the world’s problems, but we can make a significant positive impact on the people and organisations that we do work with. To achieve this, we place a focus on outcomes, which we deliver through a culture of focus, integrity, openness, and continuous technical development.

Sensius is focused on establishing thermotherapy as a key treatment modality for cancer patients alongside radiotherapy, surgery, chemotherapy, and immunotherapy. Sensius mission is to deliver optimized radiotherapy treatment outcomes for patients with head and neck cancer, by balancing efficacy with quality of life.

Sequana Medical NV is a pioneer in treating drug-resistant fluid overload, a serious and frequent clinical complication in patients with liver disease, heart failure and cancer. Fluid overload is a well-recognized problem in these growing diseases, causing severe problems for the large number of patients for whom current medicines are no longer effective. These patients can have up to 15 liters of extra fluid in their bodies, causing major medical issues including increased mortality, repeated hospitalizations, severe pain, difficult breathing and restricted mobility that severely impacts daily life. alfapump® and DSR® are Sequana Medical’s proprietary approaches that work with the body to remove this excess fluid, delivering major clinical and quality of life benefits for patients and reducing costs for healthcare systems. Sequana Medical is listed on Euronext Brussels (Ticker: SEQUA.BR) and headquartered in Ghent, Belgium. For further information, please visit www.sequanamedical.com.

ABCDx is revolutionising stroke management with the first mobile brain diagnostic platform that turns smartphones into medical devices. We equip healthcare providers with accessible tools to accurately diagnose stroke patients at point-of-care – and within only a few minutes. By pioneering the ability to decode chemical messages of the brain (brain biomarkers), we developed a clinically validated method to detect brain injury using just a single drop of blood from a finger prick. Interested to learn more or be part of the first mobile brain diagnostic platform? Our team would love to hear from you: https://www.abcdx.es/contact

Data Cabling Solutions is a Midlands based communications cabling provider with 14 years’ experience in the telecoms and networking industry. We provide cabling to business with the clear ethos of honest, reliable service at a competitive cost. We know that cabling is what we provide but this isn’t all our customers require. Service is as important as the physical solution. We always endeavour to provide both the solution and the product to so our customers are satisfied and will come back to us and refer us to other companies in need of cabling. Below are the types of cabling we provide: • Telephone or CW1308 • Category 5E • Category 6 • Category 6A • Fibre Optic Reasons to choose and work with Data Cabling solutions: - Accreditation and qualifications: o Our engineers are trained to and accredited by City and Guilds with the 3667 Level 2 Communications Cabling Full award. o Enhanced DBS checked o Asbestos Awareness fully certified by NATAS (National Asbestos Training & Accreditation Scheme) - Dedicated to cabling and associated installations What makes Data Cabling Solutions different is that we are dedicated cabling installers and this is our sole focus. We are committed to providing the right advice which then means our customers have the right solution. - Flexibility Where possible we will always accommodate our customers to make the installation as easy and have the lowest impact on their organisation. - Leaving site tidy We always tidy up after we have finished working to make sure we don’t create extra work after we have finished our installation. We also take away, when practical any rubbish and recycle as much as possible. - Building relationships Whilst we provide cabling services we know that customers require more than this. We want to build lasting relationships, and that our customers are looked after through the whole process and for any future work that is needed.

Welcome to K Line Europe GmbH - We are Europe's largest OEM clear aligner manufacturer headquartered in Düsseldorf, Germany. Spanning two production halls, we have the capacity for manufacturing up to 6 million aligners per year - CE certified, FDA approved, ISO13485 compliant, and 100% MADE IN GERMANY!

Intelligent Implants is a medical device company operating at the intersection of digital medicine and orthopedics. We develop innovative electrotherapeutic orthopedic devices to address significant unmet clinical needs. The company's SmartFuse® platform is a wirelessly enabled, active implant technology that uses an array of electrodes to stimulate, control, and monitor bone growth. Our mission is to leverage SmartFuse to develop a pipeline of smart orthopedic implants that can reduce healing times, engage patients & surgeons, enable digital surgery/robotics and ultimately improve outcomes for millions of patients.

IT solutions, Business Intelligence/Analysis, System integration, Software applications & Web applications. Technocrat Xp@ LTD is a business and technology consulting company that specializes in providing solutions to meet our clients peculiar needs and help them become better benefactors of their investment in Information Technology. We help businesses maximize their potentials, make efficient use of their data and realize quicker Return on Investment (ROI) by means of technology. We are skilled at developing risk-free solutions even as we keep your project on budget. We provide facilities, support, training to aid teaching and research and general information. Built on the foundation of a strong technological team, complimented by a focus on strategic organizational concepts, TECHNOCRAT XP@ is the perfect solution house for your organization. Driven by results, we work with you to gain a competitive advantage in the marketplace. Knowing you can rely on your tools – not work around them – gives you the edge you need to compete. TECHNOCRAT XP@ also develops and distributes flexible, scalable, and affordable solutions designed for success. TECHNOCRAT XP@’s solutions uniquely meet the needs of IT professionals and non-technical end-users—with products including some the industry’s most affordable, yet fully scalable systems. We are specialists in Infrastructure deployment (networking, customer call center automation e.t.c) and also provide various high degree of Biometric processing which we have been doing for the Pension Industry using our unique skills and expertise, and were appropriate, using our worldwide partnerships with World –class global organizations, we also offer application development services. Our application development service offers your company an opportunity to develop a competitive advantage by using technology in a more productive or effective way than your competitors. Custom development does not have to be expensive.

Volta Medical leverages artificial intelligence to revolutionize interventional cardiac electrophysiology. Its cutting-edge software solutions use machine and deep learning algorithms to assist operators during cardiac ablation procedures. Volta’s DNA is to provide physicians with solutions that are user-friendly. Its first medical device, VX1, consists of a cue-giving interface designed to facilitate the identification of abnormal electrograms during ablation of complex arrhythmias such as atrial fibrillation. With VX1, operators keep their go-to navigation system and catheters. The VX1 real-time analysis algorithm has been trained on carefully curated databases of annotated intra-cardiac electrograms. The solution may be used as a support to assist electrogram-based atrial fibrillation ablation. VX1 is CE marked and FDA cleared. VX1 was the first artificial intelligence-based software solution to be FDA cleared in the interventional cardiology space. Volta Medical is expanding at a fast rate across the globe. Multiple partnerships have been formed with leading centers in Europe and the US.

Intrasense develops and markets Myrian®, a software solution allowing medical images visualization and analysis for improved productivity and enhanced patient care. This new vendor neutral viewer features a multimodal platform and a full set of clinical modules, fully integrable in any healthcare system. Today, we equip more than 800 sites worldwide. Learn more about who we are.

TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function. Since the discovery of our first polymer at the labs of Bob Langer and Jeff Karp at MIT, we recognized the exceptional potential for our technology to revolutionize the field of tissue reconstruction in multiple therapeutic areas. Our unique approach to product development leverages the knowledge gained from the development of our technology platform comprised of proprietary polymers, activation technologies, and delivery devices. We have developed a fully integrated innovation, design, commercialization and manufacturing platform to support our internal programs as well as co-development partnerships with leaders in the medtech industry.

Titan IC is a world leader in the development of hardware accelerated intellectual property for cyber Security Analytics Acceleration (SAA) and content processing. Titan IC works with national security agencies and cybersecurity appliance OEMs as well as cloud computing providers. Our technology is designed for high throughput low latency Deep Packet Inspection (DPI) applications that require packet payload inspection which can be achieved using regular expression (RegEx) pattern matching and string matching. We enable intrusion detection and security information and event management systems to search for thousands of cyber threat signatures in parallel and at network line speed for real-time alerting or to search through large datasets to reduce the search time for cybersecurity forensics. Our technology is available as a PCIe card, a vASSP, an IP for FPGA and IP for ARM(R) based System on Chip (SOC) solutions or as an FPGA in the cloud on AWS F1. The range of applications include: Security Analytics Acceleration (SAA) Next Generation Firewall (NGFW) Deep Packet Inspection (DPI) Deep Flow Inspection (DFI) Intrusion Prevention System (IPS) Distributed Denial of Service Mitigation (DDoS) SmartNIC Network Monitoring Data Loss Prevention (DLP) Advanced auditing of user/application security policies Rule based content processing for spam, URLs, adware Financial data mining - parsing of streamed financial feeds

We are dedicated to developing and implementing clinically validated ML-based clinical decision support software that save lives and reduce costs in healthcare, primarily targeting intensive and critical care.

The Haag-Streit Group, headquartered in Koeniz near Bern, is an internationally operating Swiss medical device company in the field of eye care. The group develops, manufactures and globally distributes cutting-edge solutions and medical devices including slit lamps, tonometers, chairs and stands for the refractive workplace, as well as biometers, perimeters, surgical microscopes and further accessories. The Haag-Streit Group also offers virtual reality-based solutions and simulators for medical education. For more than 160 years, Haag-Streit has been working closely with well-respected scientists and physicians worldwide. According to the principle:” Look closer, see further”, we work with attention to detail to develop and produce innovative and progressive comprehensive solutions of highest quality for eye care specialists.

Haag-Streit Simulation is a pioneer with virtual and augmented reality simulators for medical training. Today, medical students and ophthalmologists all over the world train their diagnostic and surgical skills on high-fidelity simulators from Haag-Streit Simulation – without any stress or risk for patients. In 2020, the company has joined the Swiss-based Haag-Streit Group. There are currently around 85 employees working at Haag-Streit Simulation in Mannheim, Germany. https://www.vrmagic.com/imprint/ https://www.vrmagic.com/privacy#socialmed

Lenek is dedicated to designing, manufacturing, and marketing medical devices in India that can make medical diagnostics more convenient for both the patients and the medical institutions. We aspire to create an ecosystem of research and development around medical technologies in India with a mission to make healthcare accessible to everyone through point-of-care procedures. Reach out to us for discussions related to healthcare industry and to know more about the work we are doing.

We are a National Startup Award Winning, NextGen Healthtech startup with a vision to make healthcare diagnostics, Affordable, Accessible and Predictive. We have received various accolades, grants, funding and working in collaboration with, AIIMS Delhi, GMCH, GNRC, IITK, MeitY, DBT, DST, ICMR.

Medable's mission is to get effective therapies to patients faster. We provide an end-to-end, global cloud platform with a flexible suite of tools that allows sponsors, patients, providers & CRO's to work together as a team in clinical trials. Our solutions enable more efficient clinical research, more effective healthcare delivery, and more accurate precision and predictive medicine. Our vision is to accelerate the path to human discovery and medical cures. We are passionate about driving innovation and empowering consumers. We are proactive, collaborative, self-motivated learners, committed, bold and tenacious. We are dedicated to making this world a healthier place.

Neurofenix is an innovative digital therapeutics company empowering patients and their families to get their life back after suffering a stroke, traumatic brain injury or spinal cord injury. Our global team of highly motivated professionals includes bio-medical engineers, occupational therapists, software engineers and others. Many of us have personal experiences with neurological injuries, which inspire us in our day-to-day work. Neurofenix closed its Series A round of investment in August 2022, and is actively selling the NeuroBall platform to survivors, rehabilitation clinics and institutions for upper extremity recovery.

GIMER Medical is a Taiwan based company originally spun off from National Taiwan University. It focuses on ultrahigh frequency stimulation (+RF) therapy. The 1st product is Spinal Cord Stimulator device addressing chronic pain. In the pipeline we take this innovative treatment further and apply to other indications, hoping to make positive impacts on the quality of lives of those who suffer from different medical conditions.

“Collective force is always more powerful than individual ones.” COFORCE Medical Inc. is your med-tech partner providing innovation with existing product expertise in implantable bioelectronics. We bring components & services under one umbrella, offering you the fast access to Asian technology centerpieces.

Synaptive Medical Inc., a Toronto-based, global medical device and technology company solves surgical, imaging, and data challenges to improve the quality of human lives. Synaptive’s integrated suite of products – bridging MRI, surgical planning, navigation, and robotic visualization – delivers novel information with automated efficiency across all stages of clinical intervention.

Heru Inc. (www.seeheru.com) is a medical software company focused on the development of next-generation vision exams leveraging commercially available AR/VR head-mounted displays. The company pioneered the first multi-modal wearable solution, which has revolutionized healthcare by introducing several vision exams within a single platform. The platform’s dark adaptation exam and contrast sensitivity exams establish a market-leading AMD portfolio that may aid physicians in detecting subclinical early AMD and monitoring disease progression. Heru is leveraging its award-winning platform to build a comprehensive solution that is strongly correlated to the current standard of care and exceeds traditional standards of care in usability, cost, size, and portability. Future development includes therapeutic applications for personalized augmented vision correction. Heru was born out of the University of Miami’s Bascom Palmer Eye Institute.

Olleyes is a medical device company revolutionizing eye-care. Our innovative portable device leverages the power of virtual reality and artificial intelligence to enable eye-care providers to monitor common eye diseases remotely. Our devices allow medical professionals to monitor and diagnose patients from anywhere - a small room within the walls of the practice or at home - simultaneously leading to increased provider productivity and better patient outcomes.

When a five-year-old boy was blinded after a regular eye exam failed to spot a retinal detachment, his father made it his life’s work to help eye care professionals by revolutionising retinal imaging. Optos was founded by Douglas Anderson with the goal to make a patient-friendly device to capture a digital ultra-widefield image of the retina. Today, millions of patients around the world have benefited from optomap® retinal imaging. You will find optomap systems in many independent High Street optometrists, as well as eye clinics at Great Ormond Street Hospital in London and Harvard Medical Center in Massachusetts. Our core products produce high resolution optomap images of 82% or 200◦ of the retina, something no other imaging device is capable of in a single comfortable capture. The most recent innovation from Optos integrates ultra-widefield retinal imaging and image-guided Optical Coherence Tomography (OCT). This combined device facilitates the early detection, management and effective treatment of disorders and diseases evidenced in the retina such as retinal detachments and tears, glaucoma, diabetic retinopathy, and age-related macular degeneration. More than 1,000 published and ongoing clinical trials as well as thousands of case studies and testimonials show the long-term value of optomap imaging and OCT in diagnosis, treatment planning, and patient engagement. As a division of Nikon Co. Ltd, Japan since 2015, Optos is approaching its 30th anniversary and proud to be recognized as a leading provider of devices to eye care professionals to provide a more complete approach to patient care.

Fluxergy was founded 10 years ago with a vision to democratize the world of laboratory testing, by making testing more accessible and affordable. Fluxergy’s platform technology enables us to understand our world and our health in ways that were never possible before. Fluxergy is developing a platform with multi-modal detection technologies which bring the variety of tests found in the central lab to the palm of your hand – This includes molecular testing like PCR, Immunochemistry and chemistry testing, and microscopy testing such as cytometry. Fluxergy’s platform vision is the detection of genes, proteins, small molecules, and cells with the same analyzer. The automated, sample-to-answer workflows can be customized for specific sample and testing methods.

HumanITcare is a digital health company delivering a telemedicine platform for monitoring remotely real-life data of chronic patients using Artificial Intelligence. HumanITcare is improving clinical outcomes and reducing clinical costs by providing an accurate remote patient monitoring system.

Paramit, headquartered just outside the heart of Silicon Valley and acquired by Swiss-based Tecan Group in 2021, is dedicated to improving people’s lives and health by empowering customers to scale healthcare innovation globally. Paramit develops and manufactures electronics based medical devices and life science instruments. We offer customers around the globe access to a deep bench of engineering and product development talent, as well as access to high-quality, cost-competitive manufacturing in North America and the APAC region. Our two world class facilities, strategically located in Northern California and Penang, each span roughly 150,000 square feet and are ISO 13485 certified. Both Paramit and its parent company, Tecan, are dedicated to improving people’s lives and health-related outcomes. We share a strong customer-centric culture and a long track record of operating in highly regulated markets, which are focused on mechatronic-intensive instruments that combine custom electronics, optics, robotics and/or microfluidics. Paramit’s vertically integrated capabilities include PCB assembly, test development, optics assembly and our innovative vPoke® computer directed mechanical assembly process. vPoke, designed for high integrity manufacturing and regulated markets, provides us with comprehensive device history records and full traceability for each and every product, ensuring that we consistently meet our goal of zero defects. Our extensive team of skilled engineers and technicians are fully equipped to assist customers during all stages of the new product introduction (NPI) process, including ideation, design, prototype development, late-stage reviews, manufacturing, and post-manufacturing services. We share a commitment to excellence and are singularly focused on helping our customers successfully bring bring their products to market.

CoMind is a London based, Neurotechnology start-up developing a next-generation neurosensing platform. Their innovative neurosensing technology will catalyse a new wave of neuroscience and neurology applications within medical devices, ultimately forming a seamless interface to the brain. CoMind's technology is particularly unique, as most devices that have the ability to retrieve these signals are either invasive or come at multi-million dollar expense. Not only are CoMind's devices non-invasive and affordable, but they're also portable and will eventually be wearable, allowing them to become ubiquitous. In the long term, this neurosensing technology will form the foundations for a seamless neural interface that will allow engineers to build applications for the brain. CoMind is backed by leading investors such as Octopus Ventures, LocalGlobe and Crane Venture Partners, alongside several high profile angel investors. We are currently hiring for multiple roles: https://comind.jobs.personio.com/.

Cala Health is a bioelectronic medicine company transforming the standard of care for chronic disease. The company’s wearable neuromodulation therapies merge innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation. The first indication for Cala Health’s wearable therapy is essential tremor, a disease experienced by more than seven million people and characterized by severe hand tremors. New therapies are under development in neurology, cardiology, and psychiatry. The company is headquartered in the San Francisco Bay Area and backed by leading investors in both healthcare and technology. #EssentialTremorAwarenessMonth

We're hiring ! https://wandercraft.welcomekit.co/ Wandercraft ‘s job is to make wheelchair users walk again. We make real the promises of robotics by providing an ordinary life to extraordinary people. We have developed the first autonomous exo. In our world premiere clinical trials, persons with paraplegia walked human-like, autonomously and without crutches. The Wanderteam walks on the edge of robotics. We cooperate with world class university labs and medical centers in Europe and the US. Atalante is not only an exoskeleton. Atalante allows patients to stand up, without crutches. Atalante allows patients to finally be able to watch their loved ones in the eyes. Atalante allowed them to walk over 2 million steps. But above all, Atalante made them smile again. Atalante made 546 patients smile again. 546 patients who have chosen to place their trust in us. Join us to contribute to changing the lives of millions of persons. You will work in a supportive, fun and agile environment. You will have stunning colleagues, composing one of the best walk robotics teams in the world and chosen because they are selfless team players and not lone geniuses. Expect to be challenged: we do things that no one has done yet. Expect to have to work fast: we test and learn. Expect to have to aim at perfection: we make advanced technology exos that help mobility impaired persons and impact their health and happiness – not pizza delivery apps. Expect to get a ‘Wow’ each time you explain your job to your friends.

PlusDental wants to give everyone the chance to show their most beautiful smile by democratizing the access to state-of-the-art dental care. We are one of the fastest-growing and most invested-in MedTech companies in Europe. Since our launch in 2017, we transitioned from being a startup to becoming a scaleup and want to continue using our momentum to grow our brand. With a strong foundation in the European startup scene and dynamic partners in dentistry we meet the highest medical standards and close the gap between aesthetic dentistry and modern technology. Our Headquarter in Berlin is not only home to our Dental Lab with a team of over 150 dentists, dental technicians, and production staff, we also combine this medical excellence with almost 250 professionals with experience in fast scaling environments. We have a strong focus on our tech, data, and product teams which are active drivers in our success and a huge factor in our customer experience and the quality of our product. We pride ourselves by building broad teams in marketing and hr, having honest and authentic relationships with our patients and employees alike. We are in touch with our quality management, having an inhouse customer care and sales team, making sure we are constantly aware of the needs of our patients. In 2020 we not only raised €32 million in additional funding, we also conquered COVID-19 and still managed to maintain our growth. We treated over 35.000 patients and our clinic management and business development team supports 4 flagship clinics in Berlin, Düsseldorf, Hamburg, and Frankfurt am Main and over 200 partner clinics in Germany, Switzerland, Austria, Spain, France, Sweden, the Netherlands and the United Kingdom. Constantly expanding our network and building one of the biggest digital dentistry plattforms in Europe and China. We secured an addional €35 million in 2021. https://plusdental.de/impressum https://plusdental.de/datenschutz

Dandy was created with one goal in mind: to modernize the dental lab process. We’re the first solution of its kind. Our platform is designed to level up practices by making the entire process effortlessly digital — from start to finish.

Neocis is transforming dental implant surgery with advanced robotics. Manufacturer of Yomi, the first and only FDA-cleared robotic device for dental surgery, Neocis works closely with leading surgeons to better understand their needs and treatment challenges. The company is committed to developing innovative technologies and approaches that help advance patient care and improve quality of life.

Driven by insatiable curiosity, the love of science and passion for vision, Cassini has been dedicated to pushing the boundaries on personalized, thorough and accurate ophthalmic solutions for well over a decade. Independently, and in collaboration with our vision-care partners, we strive to make the gift of lifelong sight accessible and possible the world over. As innovative and progressive thought-leaders, we empower surgeons with the efficient, user-friendly tools, collaboration and support they need to make confident decisions for optimal outcomes. We care, and we love those who care as much as we do. Our partners in vision-care share our beliefs and together we are a formidable connection. THE WORLD IN VISION

CERHUM AT A GLANCE: We are a Belgian company which manufactures human bone grafts made of bio ceramics and act as a Medical Device CDMO, providing thousands of parts and developments as a subcontractor for big players, mainly in orthopedic surgeries. ---------------------------LEARN MORE---------------------------------- CERHUM manufactures medical devices using additive manufacturing (3D printing) in combination with advanced and innovative materials. With a 10 year-experience of industrial and in-house R&D, CERHUM has applied these additive manufacturing capabilities to bioceramics and in particular hydroxyapatite which is a well-known, tried and tested material in the medical world. The company has delivered on several R&D projects to strengthen its understanding of the material and the manufacturing process. We act as a Medical Device CDMO, providing thousands of parts and development as a subcontractor for big players, mainly in orthopedic surgeries. Our CDMO activities are both on the development and production aspects for thousands of parts as a subcontractor for large players, mainly in the field of orthopedics. Our multidisciplinary team of experts manages the entire production process: from raw materials and 3D printing to the final product. We help companies model, choose the best material and then manufacture parts, from prototype to series. Why are we unique? CERHUM prints bone grafts to heal patients in order to make their lives better. Our innovative approach combines 3 expertises: mastering the materials to produce unmatched designs, mastering the design shapes to realize controlled porosity ensuring better therapeutic results and mastering the manufacturing process to deliver high precision biocompatible bone grafts.

FindAir is a med-tech company that develops telemedicine tools for respiratory diseases. Our main product is FindAir ONE - A smart inhaler device that during normal use of an inhaler will track all valuable patients' data. Synchronized with the FindAir app and FindAir platform gives you a complete digitalization of asthma and COPD therapy. The process of remote treating and monitoring lung disease has never been so simple!

genedrive plc is a molecular diagnostics company developing and commercialising a low-cost, rapid, versatile, simple to use and robust point of need molecular platform for use in patient stratification (genotyping). We are passionate about the opportunity to build a sustainable business around molecular diagnostics and to play an important role in the diagnostic and treatment challenges presented by global health issues. The company launched the Genedrive MT-RNR1 ID Kit, a pharmacogenetic test to prevent antibiotic induced deafness in infants, which was co-developed with the partners in the UK's National Health Service and is now used for routine clinical use.

Open Bionics: Open Bionics is a prosthetics company developing affordable, assistive devices that enhance the human body. We've started by introducing the Hero Arm, a stylish multi-grip bionic arm. Current upper limb prostheses exist as hooks, grippers, or expensive bionic hands. We're on a mission to make beautiful bionic limbs more accessible. Aged 17, Joel Gibbard began tinkering with robotic hands. There was something about the movement of a disembodied humanoid hand that captured his imagination. Hundreds of prototypes and many crates of failures later, in 2014, Joel co-founded Open Bionics with Samantha Payne. With the help of an awesome team and the support of the limb different community, they’re pioneering a new bionic age inspired by science fiction. www.openbionics.com The Hero Arm: The Hero Arm is Open Bionics'​ first commercially available bionic limb. The Hero Arm is the most affordable multi-grip bionic arm ever, less than half the price of its nearest competitor. Each Hero Arm is custom-built, and for the first time ever is available for upper limb amputees as young as nine.

Össur is a leading global provider of innovative mobility solutions that help people live a Life Without Limitations®. Originally founded as an Orthotic & Prosthetic (O&P) clinic in 1971, we have been committed to providing excellent patient care and innovative mobility solutions for decades. We improve people’s mobility through our offering of prosthetics and bracing & supports solutions, and provide optimal clinical outcomes through an extensive network of patient care facilities. Significant investment in research and development have led to over 2,000 patents, award-winning designs, successful clinical outcomes, and consistently strong market positions. Össur is signatory to the UN Global Compact, UN Women’s Empowerment Principles, contributes to the UN Sustainable Development Goals and has committed to becoming Net Zero in 2050 through the Science Based Targets initiative. Össur has operations in more than 36 countries worldwide and employs around 4000 employees. We embrace diversity and pride ourselves on a strong company culture based on our core values of Honesty, Frugality and Courage.

RTsafe is a medical technology company that has developed a unique approach to quality assurance that significantly enhances the safety and accuracy of radiotherapy for cancer and other medical conditions. Our Vision Helping to create a world where every radiotherapy intervention is tested on a personalized phantom before the real patient, thus enhancing safety and effectiveness of treatment. We combine proven expertise in medical physics with highly accurate 3D printing technology to create pseudo‐in‐vivo dosimetry phantoms for end‐to‐end commissioning, benchmarking and patient‐specific quality assurance in SRS, IMRT, VMAT and SBRT applications. The anatomically accurate models enable medical professionals to plan more precise treatment interventions for each individual patient and help radiotherapy technology industry to fine‐tune its products. The result is more effective individualized therapy and reduced patient risk.